Skip Navigation



International Immunology Advance Access published online on July 12, 2004

International Immunology, doi:10.1093/intimm/dxh126
© 2004 by The Japanese Society for Immunology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/9/1241    most recent
dxh126v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schramm, C.
Right arrow Articles by Blessing, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schramm, C.
Right arrow Articles by Blessing, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received March 26, 2004
Accepted June 14, 2004

Article

TGF{beta} regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo

Christoph Schramm 1*, Samuel Huber 1, Martina Protschka 1, P. Czochra 1, Jürgen Burg 2, Edgar Schmitt 3, Ansgar W. Lohse 1, Peter R. Galle 1, Manfred Blessing 4

1 Department of Medicine, Johannes Gutenberg-University, Mainz, Germany
2 Institute of Pathology, Johannes Gutenberg-University, Mainz, Germany
3 Institute of Immunology, Faculty of Medicine, Johannes Gutenberg-University, Mainz, Germany
4 Department of Medicine, Johannes Gutenberg-University, Mainz, Germany; Faculty of Veterinary Medicine, Center for Biotechnology and Biomedicine, University of Leipzig, Leipzig, Germany

* To whom correspondence should be addressed. E-mail: schramm{at}uni-mainz.de.


   Abstract

Factors influencing the development of CD4+CD25+ T-cells in vivo are poorly understood. In order to investigate the contribution of TGF{beta}1 to the development and function of CD4+CD25+ T-cells, we generated a gain of function mutation resulting in the overexpression of an active form of TGF{beta}1 in T-cells under control of the human CD2 promoter. In peripheral lymphoid organs and in the thymus, the frequency of CD4+CD25+ T-cells was increased in transgenic mice. This appeared to be due to an autocrine effect of TGF{beta} on T-cells, since concomitant impairment of TGF{beta}-signaling in double transgenic mice resulted in a phenotype similar to wild type. In contrast, in single transgenic mice with impaired TGF{beta}-signaling in T-cells, CD4+CD25+ T-cell numbers were reduced in peripheral lymphoid organs but not in the thymus. In addition, TGF{beta} was found to regulate the expression of Foxp3 in vivo, a transcription factor essential for the generation and function of regulatory T-cells. In CD4+CD25+ T-cells, TGF{beta}1 increased the expression of Foxp3, whereas a decreased expression was seen in CD4+CD25+ T-cells with impaired TGF{beta}-signaling. TGF{beta}1 induced the expression of IL-10 in transgenic T-cells, but the increased in vitro suppressive capacity observed in transgenic CD4+CD25+ T-cells was due to the secretion of TGF{beta} and not IL-10. Therefore, our study provides in vivo evidence for a role of TGF{beta} in the homeostasis of CD4+CD25+ T-cells.

Keywords: IL-10; regulatory T-cells; TGF{beta}-signalling; thymus; tolerance.

The first two authors have contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Huber, F. R. Stahl, J. Schrader, S. Luth, K. Presser, A. Carambia, R. A. Flavell, S. Werner, M. Blessing, J. Herkel, et al.
Activin A Promotes the TGF-{beta}-Induced Conversion of CD4+CD25- T Cells into Foxp3+ Induced Regulatory T Cells
J. Immunol., April 15, 2009; 182(8): 4633 - 4640.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. H. Friedline, D. S. Brown, H. Nguyen, H. Kornfeld, J. Lee, Y. Zhang, M. Appleby, S. D. Der, J. Kang, and C. A. Chambers
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance
J. Exp. Med., February 16, 2009; 206(2): 421 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Presser, D. Schwinge, M. Wegmann, S. Huber, S. Schmitt, A. Quaas, J. H. Maxeiner, S. Finotto, A. W. Lohse, M. Blessing, et al.
Coexpression of TGF-{beta}1 and IL-10 Enables Regulatory T Cells to Completely Suppress Airway Hyperreactivity
J. Immunol., December 1, 2008; 181(11): 7751 - 7758.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. B. Samon, A. Champhekar, L. M. Minter, J. C. Telfer, L. Miele, A. Fauq, P. Das, T. E. Golde, and B. A. Osborne
Notch1 and TGF{beta}1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells
Blood, September 1, 2008; 112(5): 1813 - 1821.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. B. Glick, R. Perez-Lorenzo, and J. Mohammed
Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis
Carcinogenesis, January 1, 2008; 29(1): 9 - 14.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. V. Johnson, C. B. Camras, and J. Kipnis
Bacterial DNA Confers Neuroprotection after Optic Nerve Injury by Suppressing CD4+CD25+ Regulatory T-Cell Activity
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3441 - 3449.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S.-J. Liu, J.-P. Tsai, C.-R. Shen, Y.-P. Sher, C.-L. Hsieh, Y.-C. Yeh, A.-H. Chou, S.-R. Chang, K.-N. Hsiao, F.-W. Yu, et al.
Induction of a distinct CD8 Tnc17 subset by transforming growth factor-{beta} and interleukin-6
J. Leukoc. Biol., August 1, 2007; 82(2): 354 - 360.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. P. Singh, A. La Cava, M. Wong, F. Ebling, and B. H. Hahn
CD8+ T Cell-Mediated Suppression of Autoimmunity in a Murine Lupus Model of Peptide-Induced Immune Tolerance Depends on Foxp3 Expression
J. Immunol., June 15, 2007; 178(12): 7649 - 7657.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Carrier, J. Yuan, V. K. Kuchroo, and H. L. Weiner
Th3 Cells in Peripheral Tolerance. I. Induction of Foxp3-Positive Regulatory T Cells by Th3 Cells Derived from TGF-beta T Cell-Transgenic Mice
J. Immunol., January 1, 2007; 178(1): 179 - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Cassan, E. Piaggio, J. P. Zappulla, L. T. Mars, N. Couturier, F. Bucciarelli, S. Desbois, J. Bauer, D. Gonzalez-Dunia, and R. S. Liblau
Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells
J. Immunol., August 1, 2006; 177(3): 1552 - 1560.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Bobik
Transforming Growth Factor-{beta}s and Vascular Disorders
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1712 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Wing, Z. Fehervari, and S. Sakaguchi
Emerging possibilities in the development and function of regulatory T cells
Int. Immunol., July 1, 2006; 18(7): 991 - 1000.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Shimoda, F. Mmanywa, S. K. Joshi, T. Li, K. Miyake, J. Pihkala, J. A. Abbas, and P. A. Koni
Conditional Ablation of MHC-II Suggests an Indirect Role for MHC-II in Regulatory CD4 T Cell Maintenance.
J. Immunol., June 1, 2006; 176(11): 6503 - 6511.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. E. Fecci, D. A. Mitchell, J. F. Whitesides, W. Xie, A. H. Friedman, G. E. Archer, J. E. Herndon II, D. D. Bigner, G. Dranoff, and J. H. Sampson
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
Cancer Res., March 15, 2006; 66(6): 3294 - 3302.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. G. Zheng, L. Meng, J. H. Wang, M. Watanabe, M. L. Barr, D. V. Cramer, J. D. Gray, and D. A. Horwitz
Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient
Int. Immunol., February 1, 2006; 18(2): 279 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. H. Hahn, R. P. Singh, A. La Cava, and F. M. Ebling
Tolerogenic Treatment of Lupus Mice with Consensus Peptide Induces Foxp3-Expressing, Apoptosis-Resistant, TGF{beta}-Secreting CD8+ T Cell Suppressors
J. Immunol., December 1, 2005; 175(11): 7728 - 7737.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. W. Smith and C. Nagler-Anderson
Preventing Intolerance: The Induction of Nonresponsiveness to Dietary and Microbial Antigens in the Intestinal Mucosa
J. Immunol., April 1, 2005; 174(7): 3851 - 3857.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. Fahlen, S. Read, L. Gorelik, S. D. Hurst, R. L. Coffman, R. A. Flavell, and F. Powrie
T cells that cannot respond to TGF-{beta} escape control by CD4+CD25+ regulatory T cells
J. Exp. Med., March 7, 2005; 201(5): 737 - 746.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Huber, C. Schramm, H. A. Lehr, A. Mann, S. Schmitt, C. Becker, M. Protschka, P. R. Galle, M. F. Neurath, and M. Blessing
Cutting Edge: TGF-{beta} Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells
J. Immunol., December 1, 2004; 173(11): 6526 - 6531.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.